annual shareholders equity:
$309.85M+$63.94M(+26.00%)Summary
- As of today (August 1, 2025), ELVN annual stockholders equity is $309.85 million, with the most recent change of +$63.94 million (+26.00%) on December 31, 2024.
- During the last 3 years, ELVN annual shareholders equity has risen by +$352.73 million (+822.47%).
- ELVN annual shareholders equity is now at all-time high.
Performance
ELVN Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$288.30M-$21.55M(-6.95%)Summary
- As of today (August 1, 2025), ELVN quarterly stockholders equity is $288.30 million, with the most recent change of -$21.55 million (-6.95%) on March 31, 2025.
- Over the past year, ELVN quarterly shareholders equity has dropped by -$29.42 million (-9.26%).
- ELVN quarterly shareholders equity is now -9.26% below its all-time high of $317.71 million, reached on March 31, 2024.
Performance
ELVN quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ELVN Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.0% | -9.3% |
| 3 y3 years | +822.5% | - |
| 5 y5 years | +1626.0% | +772.2% |
ELVN Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +503.3% | -9.3% | +475.3% |
| 5 y | 5-year | at high | +503.3% | -9.3% | +475.3% |
| alltime | all time | at high | +503.3% | -9.3% | +475.3% |
ELVN Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $288.30M(-7.0%) |
| Dec 2024 | $309.85M(+26.0%) | $309.85M(+7.4%) |
| Sep 2024 | - | $288.40M(-5.4%) |
| Jun 2024 | - | $304.93M(-4.0%) |
| Mar 2024 | - | $317.71M(+29.2%) |
| Dec 2023 | $245.91M | $245.91M(-6.1%) |
| Sep 2023 | - | $261.75M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $278.99M(-4.3%) |
| Mar 2023 | - | $291.42M(-479.3%) |
| Dec 2022 | -$76.83M(+79.1%) | -$76.83M(+12.8%) |
| Sep 2022 | - | -$68.10M(+58.8%) |
| Dec 2021 | -$42.89M(+111.2%) | - |
| Dec 2021 | - | -$42.89M |
| Dec 2020 | -$20.30M | - |
FAQ
- What is Enliven Therapeutics, Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual shareholders equity year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly shareholders equity year-on-year change?
What is Enliven Therapeutics, Inc. annual stockholders equity?
The current annual shareholders equity of ELVN is $309.85M
What is the all time high annual shareholders equity for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual stockholders equity is $309.85M
What is Enliven Therapeutics, Inc. annual shareholders equity year-on-year change?
Over the past year, ELVN annual stockholders equity has changed by +$63.94M (+26.00%)
What is Enliven Therapeutics, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of ELVN is $288.30M
What is the all time high quarterly shareholders equity for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly stockholders equity is $317.71M
What is Enliven Therapeutics, Inc. quarterly shareholders equity year-on-year change?
Over the past year, ELVN quarterly stockholders equity has changed by -$29.42M (-9.26%)